UB

Usha Batra

Director Director DIN 02143861
DIN 02143861 First appointment May 2008 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2008
Shareholding value •••• Premium profile

About Usha Batra

Data last updated:

Usha Batra was a Director at Surbhi Clinic Private Limited (2011–2013) and Director at Sia Tex Private Limited (2008–2018). The companies operate in Healthcare and Manufacturing.

DIN 02143861
Primary Designation Director
Industry Healthcare
First Appointment 01 May 2008

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Surbhi Clinic Private Limited U85110DL2007PTC161600
Director01 Jun 20112007Strike Off
Sia Tex Private Limited U17299DL2007PTC158803
Director01 May 20082007Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Surbhi Clinic Private Limited
Sia Tex Private Limited
Premium access

Shareholding and investment profile for Usha Batra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Usha Batra

Usha Batra was first appointed on 01 May 2008 as Director at Sia Tex Private Limited. The most recent appointment on record is 01 Jun 2011 at Surbhi Clinic Private Limited.

Usha Batra held 2 earlier board appointments: Surbhi Clinic Private Limited (Director, 01 Jun 2011 to 01 Oct 2013); Sia Tex Private Limited (Director, 01 May 2008 to 07 Feb 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available